Trial Profile
Phase I trial investigating the tolerability of AEZS 120 in patients with prostate cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Sep 2012
Price :
$35
*
At a glance
- Drugs AEZS 120 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 24 Sep 2012 Planned initiation date changed from 1 Jun 2012 to 1 Dec 2012.
- 11 Aug 2011 Planned initiation date changed to 1 Jun 2012.
- 22 Jul 2011 New trial record